Maria Rafalski

Title: Maria Rafalski: Innovator in Pharmaceutical Chemistry

Introduction

Maria Rafalski is a prominent inventor based in Wilmington, DE (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel cyclic compounds that serve as inhibitors of platelet glycoprotein IIb/IIIa.

Latest Patents

Maria holds a patent for her invention titled "Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA." This invention relates to novel cyclic compounds containing carbocyclic ring systems that act as antagonists of the platelet glycoprotein IIb/IIIa complex. The patent outlines pharmaceutical compositions that include these cyclic compounds, which can be used alone or in combination with other therapeutic agents. The compounds are designed for the inhibition of platelet aggregation, serving as thrombolytics, and for the treatment of various thromboembolic disorders. A representative compound from her patent is cyclo(D-Val-(.sup..alpha. N-methyl Arg)-Gly-Asp-(3-aminomethylbenzoic acid).

Career Highlights

Maria Rafalski is associated with The Dupont Merck Pharmaceutical Company, where she has been instrumental in advancing research and development in her field. Her work has led to innovative solutions for treating thromboembolic disorders, showcasing her expertise and dedication to improving patient outcomes.

Collaborations

Maria has collaborated with notable colleagues, including Shaker Ahmed Mousa and Michael Sworin. These partnerships have contributed to the successful development of her patented compounds and have fostered a collaborative environment for innovation.

Conclusion

Maria Rafalski's contributions to pharmaceutical chemistry, particularly through her innovative patent, highlight her role as a leading inventor in the field. Her work continues to impact the treatment of thromboembolic disorders, demonstrating the importance of innovation in healthcare.